Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Evolutionary Relationships through Genome Comparisons02:54

Evolutionary Relationships through Genome Comparisons

Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The correlation between copy number variation in Chromosome 14 and DNA methylation in Saudi autistic children.

European review for medical and pharmacological sciences·2022
Same author

Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells.

Annual review of medicine·2022
Same author

The Macrophage 'Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

The pattern of invasive lobular carcinoma in the patients diagnosed with breast cancer from Balochistan.

Indian journal of cancer·2017
Same author

[First stage in identifying traumatic profil inpatients hospitalised in psychiatry in Martinique].

Sante mentale au Quebec·2015
Same author

Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis.

Leukemia·2014

Related Experiment Video

Updated: May 24, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Clonal evolution of acute leukemia genomes.

M Jan1, R Majeti

  • 1Department of Medicine, Division of Hematology, Cancer Institute, Stanford University School of Medicine, Palo Alto, CA, USA.

Oncogene
|February 22, 2012
PubMed
Summary

Cancer evolves through accumulated mutations and clonal selection. Advanced genomics reveals complex subclone diversity in acute leukemia, impacting relapse and pre-cancerous mutations, crucial for targeted therapies.

Area of Science:

  • Oncology
  • Genetics
  • Cancer Biology

Background:

  • Cancer develops from accumulated mutations and clonal evolution.
  • Understanding cancer subclones is vital for treating refractory and relapsed disease.
  • Genomic techniques are increasingly used to study cancer evolution.

Purpose of the Study:

  • To review recent genomic studies on acute leukemia clonal evolution.
  • To discuss the clinical implications of clonal diversity in acute leukemia.
  • To highlight findings on subclones in relapse and pre-leukemic mutations.

Main Methods:

  • Review of recent genomic studies in acute leukemia.
  • Analysis of data on clonal architecture and evolution.
  • Synthesis of findings on pediatric acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).

More Related Videos

Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Experiment Videos

Last Updated: May 24, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Main Results:

  • Acute leukemia exhibits complex genetic subclone diversity within individual patients.
  • Relapse in acute leukemia can originate from ancestral clones, not just dominant ones.
  • Pre-leukemic mutations have been identified in some acute leukemia cases.

Conclusions:

  • Genomic insights into acute leukemia clonal evolution are critical for understanding disease progression.
  • Knowledge of subclone diversity and origins informs therapeutic strategies.
  • Further research is needed to translate these findings into improved patient outcomes.